Legal status · Canada
Is Visepegenatide legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Visepegenatide is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile.
Visepegenatide in Canada at a glance
| Classification | Not approved |
|---|---|
| Note | No Health Canada submission located. |
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 4 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Visepegenatide profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Visepegenatide is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Visepegenatide is
A published phase 3 in 273 treatment-naive Chinese adults cut glycated haemoglobin 1.36 percentage points against 0.63 on placebo at 24 weeks, and it needs no dose titration. In its phase 1 study 28 percent of healthy volunteers developed antidrug antibodies.
Visepegenatide is exenatide with a polyethylene glycol chain attached, which turns a twice-daily injection into a once-weekly one. It comes from PegBio in Hangzhou and carried the development code PB-119 through most of its published literature.
Mechanism: Exenatide, a synthetic version of exendin-4 from Gila monster venom that acts as a GLP-1 receptor agonist, covalently modified with polyethylene glycol. The PEG chain increases hydrodynamic radius and slows renal clearance, extending half-life from the few hours of native exenatide to around 55 hours, which supports weekly dosing at a fixed dose.
Regulatory history: Not approved in the United States. Reported approved in China in November 2025 after the published phase 3; this site has not resolved a Chinese regulatory document, so treat the approval date as reported rather than as verified here.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Visepegenatide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Visepegenatide in other countries
Frequently asked questions
Is Visepegenatide legal in Canada?
No. Visepegenatide is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile. Note: No Health Canada submission located.
Can I buy Visepegenatide in Canada?
No approved product exists to buy. In Canada Visepegenatide is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No Health Canada submission located.
Is Visepegenatide Health Canada approved?
No. In Canada Visepegenatide is classified as "Not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved in the United States. Reported approved in China in November 2025 after the published phase 3; this site has not resolved a Chinese regulatory document, so treat the approval date as reported rather than as verified here.. On the evidence, 4 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Visepegenatide live on its compound profile.
Visepegenatide profileThis page is general information about the regulatory status of Visepegenatide in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.